SERUM IL-2 RECEPTOR LEVELS CORRELATE WITH DISEASE-ACTIVITY AND RESPONSE TO HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY IN DERMATOMYOSITIS AND POLYMYOSITIS OVERLAP SYNDROMES
I. Gottfried et al., SERUM IL-2 RECEPTOR LEVELS CORRELATE WITH DISEASE-ACTIVITY AND RESPONSE TO HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY IN DERMATOMYOSITIS AND POLYMYOSITIS OVERLAP SYNDROMES, Journal of investigative dermatology, 105(3), 1995, pp. 499-499